N-[(3S,4R)-3-hydroxytetrahydropyran-4-yl]-1-methyl-4-[(4-thiazol-2-ylphenyl)methyl]pyrrolo[2,3-b]pyridine-6-carboxamide

ID: ALA4237601

Chembl Id: CHEMBL4237601

PubChem CID: 145984661

Max Phase: Preclinical

Molecular Formula: C24H24N4O3S

Molecular Weight: 448.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ccc2c(Cc3ccc(-c4nccs4)cc3)cc(C(=O)N[C@@H]3CCOC[C@H]3O)nc21

Standard InChI:  InChI=1S/C24H24N4O3S/c1-28-9-6-18-17(12-15-2-4-16(5-3-15)24-25-8-11-32-24)13-20(26-22(18)28)23(30)27-19-7-10-31-14-21(19)29/h2-6,8-9,11,13,19,21,29H,7,10,12,14H2,1H3,(H,27,30)/t19-,21-/m1/s1

Standard InChI Key:  AUKATKSQEIQIBB-TZIWHRDSSA-N

Alternative Forms

  1. Parent:

    ALA4237601

    ---

Associated Targets(Human)

CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm1 Muscarinic acetylcholine receptor M1 (3437 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 448.55Molecular Weight (Monoisotopic): 448.1569AlogP: 3.17#Rotatable Bonds: 5
Polar Surface Area: 89.27Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.78CX Basic pKa: 2.66CX LogP: 2.95CX LogD: 2.95
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.49Np Likeness Score: -0.72

References

1. Engers JL, Childress ES, Long MF, Capstick RA, Luscombe VB, Cho HP, Dickerson JW, Rook JM, Blobaum AL, Niswender CM, Engers DW, Conn PJ, Lindsley CW..  (2018)  VU6007477, a Novel M1 PAM Based on a Pyrrolo[2,3-b]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events.,  (9): [PMID:30258541] [10.1021/acsmedchemlett.8b00261]

Source